← All trials
NCT00865969
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 1, 2008
- Primary completion
- Oct 1, 2014
- Completion date
- Oct 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 129
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Spectrum PharmaceuticalsLead sponsor
- ValerioCollaborator
- CHU Mont-GodinneOverall official - principal investigator
- Henry Ford Health SystemOverall official - principal investigator
- Wayne State UniversityOverall official - principal investigator
- Drs Pirjol, Szpak and Moodley Inc, Durban, South AfricaOverall official - principal investigator
- Isala Clinics, Zwolle, The NetherlandsOverall official - principal investigator
- Cascade Cancer CenterOverall official - principal investigator
- Morristown Memorial HospitalOverall official - principal investigator
- Boca Raton Clinical Research AssociatesOverall official - principal investigator
- Bronx River Medical Associates, PCOverall official - principal investigator
- City of Hope National Medical CenterOverall official - principal investigator
- McGill UniversityOverall official - principal investigator
- New York UniversityOverall official - principal investigator
- University of GroningenOverall official - principal investigator
- Stellenbosch UniversityOverall official - principal investigator
- University of LiegeOverall official - principal investigator
- Pretoria Academic HospitalOverall official - principal investigator
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
- Philipps University of MarburgOverall official - principal investigator
- Université catholique de LouvainOverall official - principal investigator
- University of ChicagoOverall official - principal investigator
- University of WashingtonOverall official - principal investigator
- Boston UniversityOverall official - principal investigator
- Universitario de Santiago, SpainOverall official - principal investigator
- State University of New York, SyracuseOverall official - principal investigator
- Washington University in St. LouisOverall official - principal investigator
- Free University of AmsterdamOverall official - principal investigator
- Universidad Autonoma de BarcelonaOverall official - principal investigator
- Pennsylvania State UniversityOverall official - principal investigator
- State University of New York, BuffaloOverall official - principal investigator
- University of Texas at HoustonOverall official - principal investigator
- Virginia Commonwealth UniversityOverall official - principal investigator
- National Cancer Institute (NCI)Overall official - principal investigator
- Hospital Universitario Central de AsturiasOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.